WORK Medical Technology (WOK) Debt to Equity (2023 - 2025)

WORK Medical Technology (WOK) reported Debt to Equity of $0.3 for Q3 2025, down 63.58% on a YoY basis from $0.83 in Q3 2024, and down 64.22% quarter-over-quarter from $0.84 in Q1 2025.

WORK Medical Technology (WOK) Debt to Equity (2023 - 2025) Analysis & Trends

WORK Medical Technology has reported Debt to Equity for 3 years, with the latest figure at $0.3 in Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity fell 63.58% year-over-year to $0.3; the trailing twelve-month figure through Sep 2025 stood at $0.3 (down 63.58% YoY), and the FY2025 full-year result was $0.3, down 63.58% from the prior year.
  • Debt to Equity for Q3 2025 stood at $0.3, down from $0.84 in the prior quarter.
  • The five-year high for Debt to Equity was $0.84 in Q1 2025, with the low at $0.3 in Q3 2025.
  • Historically, Debt to Equity has averaged $0.69 across 3 years, with a median of $0.82 in 2023.
  • Annual changes were most pronounced in 2024 — Debt to Equity climbed 3.03% — and 2025, when it slumped 63.58%.
  • WORK Medical Technology's Debt to Equity stood at $0.8 in 2023, then climbed by 3.03% to $0.83 in 2024, then tumbled by 63.58% to $0.3 in 2025.
  • The last three Debt to Equity figures came in at $0.3 (Q3 2025), $0.84 (Q1 2025), and $0.83 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 WORK Medical Technology - - - 0.30

Historic Data

Download Data
DateValue
Sep 30, 2025 0.30
Mar 31, 2025 0.84
Sep 30, 2024 0.83
Sep 30, 2023 0.80